{"pmid":32500647,"title":"Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.","text":["Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.","Dermatol Ther","Yozgat, Can Yilmaz","Uzuner, Selcuk","Duramaz, Burcu Bursal","Yozgat, Yilmaz","Erenberk, Ufuk","Iscan, Akin","Turel, Ozden","32500647"],"journal":"Dermatol Ther","authors":["Yozgat, Can Yilmaz","Uzuner, Selcuk","Duramaz, Burcu Bursal","Yozgat, Yilmaz","Erenberk, Ufuk","Iscan, Akin","Turel, Ozden"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500647","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/dth.13770","keywords":["covid-19","kawasaki disease","pediatrics multisystem inflammatory syndrome"],"topics":["Case Report"],"weight":1,"_version_":1668804508801564672,"score":9.490897,"similar":[{"pmid":32463092,"title":"Multisystem Inflammatory Syndrome in Children during the COVID-19 pandemic: a case series.","text":["Multisystem Inflammatory Syndrome in Children during the COVID-19 pandemic: a case series.","We present a series of six critically ill children with Multisystem Inflammatory Syndrome in Children (MIS-C). Key findings of this syndrome include fever, diarrhea, shock, and variable presence of rash, conjunctivitis, extremity edema, and mucous membrane changes.","J Pediatric Infect Dis Soc","Chiotos, Kathleen","Bassiri, Hamid","Behrens, Edward M","Blatz, Allison M","Chang, Joyce","Diorio, Caroline","Fitzgerald, Julie C","Topjian, Alexis","John, Audrey R Odom","32463092"],"abstract":["We present a series of six critically ill children with Multisystem Inflammatory Syndrome in Children (MIS-C). Key findings of this syndrome include fever, diarrhea, shock, and variable presence of rash, conjunctivitis, extremity edema, and mucous membrane changes."],"journal":"J Pediatric Infect Dis Soc","authors":["Chiotos, Kathleen","Bassiri, Hamid","Behrens, Edward M","Blatz, Allison M","Chang, Joyce","Diorio, Caroline","Fitzgerald, Julie C","Topjian, Alexis","John, Audrey R Odom"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463092","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1093/jpids/piaa069","keywords":["covid-19","kawasaki disease","sars-cov-2","multisystem inflammatory syndrome in children"],"locations":["Children"],"topics":["Case Report"],"weight":1,"_version_":1668079521508622337,"score":111.48964},{"pmid":32462354,"title":"Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic.","text":["Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic.","There is a global concern of increasing number of children presenting with inflammatory syndrome with clinical features simulating Kawasaki disease, during ongoing COVID-19 pandemic. The authors report a very similar case of 5-y-old boy from a COVID-19 hotspot area who presented in late April 2020 with acute febrile illness with abdominal pain and loose stools followed by shock. On examination, child had bulbar conjunctivitis and extremity edema. Initial investigations showed high inflammatory parameters, elevated serum creatinine and liver enzymes. Echocardiography showed moderate LV dysfunction and normal coronaries. Cardiac enzymes were also elevated, suggesting myocarditis. He was treated with inotropic support, respiratory support with high flow nasal cannula, IV immunoglobulins, aspirin, steroids and diuretics. RT PCR for SARS-CoV-2 was negative twice. His clinical condition improved rapidly, was afebrile from day 2, inflammatory parameters decreased, left ventricular function improved and was discharged after 6 d of hospital stay.","Indian J Pediatr","Rauf, Abdul","Vijayan, Ajay","John, Shaji Thomas","Krishnan, Raghuram","Latheef, Abdul","32462354"],"abstract":["There is a global concern of increasing number of children presenting with inflammatory syndrome with clinical features simulating Kawasaki disease, during ongoing COVID-19 pandemic. The authors report a very similar case of 5-y-old boy from a COVID-19 hotspot area who presented in late April 2020 with acute febrile illness with abdominal pain and loose stools followed by shock. On examination, child had bulbar conjunctivitis and extremity edema. Initial investigations showed high inflammatory parameters, elevated serum creatinine and liver enzymes. Echocardiography showed moderate LV dysfunction and normal coronaries. Cardiac enzymes were also elevated, suggesting myocarditis. He was treated with inotropic support, respiratory support with high flow nasal cannula, IV immunoglobulins, aspirin, steroids and diuretics. RT PCR for SARS-CoV-2 was negative twice. His clinical condition improved rapidly, was afebrile from day 2, inflammatory parameters decreased, left ventricular function improved and was discharged after 6 d of hospital stay."],"journal":"Indian J Pediatr","authors":["Rauf, Abdul","Vijayan, Ajay","John, Shaji Thomas","Krishnan, Raghuram","Latheef, Abdul"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462354","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s12098-020-03357-1","keywords":["covid-19","children","inflammatory syndrome","kawasaki disease","multi-organ dysfunction"],"locations":["Kawasaki"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"e_drugs":["Aspirin","Steroids","Creatinine"],"topics":["Case Report"],"weight":1,"_version_":1668079521424736257,"score":108.883125},{"pmid":32441749,"title":"COVID-19 Associated Pediatric Multi-System Inflammatory Syndrome.","text":["COVID-19 Associated Pediatric Multi-System Inflammatory Syndrome.","J Pediatric Infect Dis Soc","Deza Leon, M P","Redzepi, A","McGrath, E","Abdel-Haq, N","Shawaqfeh, A","Sethuraman, U","Tilford, B","Chopra, T","Arora, H","Ang, J","Asmar, B","32441749"],"journal":"J Pediatric Infect Dis Soc","authors":["Deza Leon, M P","Redzepi, A","McGrath, E","Abdel-Haq, N","Shawaqfeh, A","Sethuraman, U","Tilford, B","Chopra, T","Arora, H","Ang, J","Asmar, B"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32441749","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/jpids/piaa061","keywords":["covid-19","incomplete kawasaki disease","kawasaki shock syndrome","kawasaki disease","pediatric multi-system inflammatory syndrome temporally associated with covid-19"],"topics":["Case Report"],"weight":1,"_version_":1667523504690429952,"score":100.820366},{"pmid":32455505,"title":"Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.","text":["Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.","We read with interest the publications in the JEADV which reported dermatological manifestations associated with COVID-19, such as pityriasis rosea, urticaria, rash, vascular signs, or chilblain-like lesions. Herein, we report two life-threatening cases of children presenting with fever and eruptions with mucous membrane involvement - erythema multiforme and Kawasaki disease - associated with COVID-19.","J Eur Acad Dermatol Venereol","Labe, P","Ly, A","Sin, C","Nasser, M","Chapelon-Fromont, E","Ben Said, P","Mahe, E","32455505"],"abstract":["We read with interest the publications in the JEADV which reported dermatological manifestations associated with COVID-19, such as pityriasis rosea, urticaria, rash, vascular signs, or chilblain-like lesions. Herein, we report two life-threatening cases of children presenting with fever and eruptions with mucous membrane involvement - erythema multiforme and Kawasaki disease - associated with COVID-19."],"journal":"J Eur Acad Dermatol Venereol","authors":["Labe, P","Ly, A","Sin, C","Nasser, M","Chapelon-Fromont, E","Ben Said, P","Mahe, E"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32455505","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/jdv.16666","keywords":["covid-19","kawasaki disease","coranovirus","erythema multiforme"],"locations":["Kawasaki","Kawasaki"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"topics":["Case Report"],"weight":1,"_version_":1667881798469681153,"score":63.917847},{"pmid":32471782,"title":"Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department.","text":["Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department.","The 2019 coronavirus disease (COVID-19) has not appeared to affect children as severely as adults. However, approximately 1 month after the COVID-19 peak in New York City in April 2020, cases of children with prolonged fevers abruptly developing inflammatory shock-like states have been reported in Western Europe and the United States. This case series describes four previously healthy children with COVID-19 infection confirmed by serologic antibody testing, but negative by nasopharyngeal RT-PCR swab, presenting to the Pediatric Emergency Department (PED) with prolonged fever (5 or more days) and abrupt onset of hemodynamic instability with elevated serologic inflammatory markers and cytokine levels (IL-6, IL-8 and TNF-alpha). Emergency physicians must maintain a high clinical suspicion for this COVID-19 associated post-infectious cytokine release syndrome, with features that overlap with Kawasaki Disease (KD) and Toxic Shock Syndrome (TSS) in children with recent or current COVID-19 infection, as patients can decompensate quickly.","Am J Emerg Med","Waltuch, Temima","Gill, Prakriti","Zinns, Lauren E","Whitney, Rachel","Tokarski, Julia","Tsung, James W","Sanders, Jennifer E","32471782"],"abstract":["The 2019 coronavirus disease (COVID-19) has not appeared to affect children as severely as adults. However, approximately 1 month after the COVID-19 peak in New York City in April 2020, cases of children with prolonged fevers abruptly developing inflammatory shock-like states have been reported in Western Europe and the United States. This case series describes four previously healthy children with COVID-19 infection confirmed by serologic antibody testing, but negative by nasopharyngeal RT-PCR swab, presenting to the Pediatric Emergency Department (PED) with prolonged fever (5 or more days) and abrupt onset of hemodynamic instability with elevated serologic inflammatory markers and cytokine levels (IL-6, IL-8 and TNF-alpha). Emergency physicians must maintain a high clinical suspicion for this COVID-19 associated post-infectious cytokine release syndrome, with features that overlap with Kawasaki Disease (KD) and Toxic Shock Syndrome (TSS) in children with recent or current COVID-19 infection, as patients can decompensate quickly."],"journal":"Am J Emerg Med","authors":["Waltuch, Temima","Gill, Prakriti","Zinns, Lauren E","Whitney, Rachel","Tokarski, Julia","Tsung, James W","Sanders, Jennifer E"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32471782","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ajem.2020.05.058","keywords":["covid-19","children","cytokine storm","kawasaki disease"],"locations":["New York","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1668255193350799361,"score":63.463394}]}